Studies have shown that IL-2 and IL-15 induce the expression of CD107a (degranulation marker) on γδ T cells and give these cells their tumor cell-killing ability and that exogenous IL-2 and IL-15 also enhance the effector functions (especially degranulation/cytotoxic potential) of γδ T cells [91]. This evidence concerns the gene IL2 and neoplasm.